Puma Biotechnology, Inc.

Release Summary

Puma Biotechnology announced the publication of abstracts on its lead drug candidate neratinib for the AACR Annual Meeting 2017, which will be held from April 1 - 5, 2017.

Puma Biotechnology, Inc.